873 related articles for article (PubMed ID: 23702928)
21. Development of the peripheral sympathetic nervous system in zebrafish.
Stewart RA; Look AT; Kanki JP; Henion PD
Methods Cell Biol; 2004; 76():237-60. PubMed ID: 15602879
[No Abstract] [Full Text] [Related]
22. Emerging importance of ALK in neuroblastoma.
Azarova AM; Gautam G; George RE
Semin Cancer Biol; 2011 Oct; 21(4):267-75. PubMed ID: 21945349
[TBL] [Abstract][Full Text] [Related]
23. [Recent advances in neuroblastoma research].
Imaizumi M
Seikagaku; 2004 May; 76(5):453-6. PubMed ID: 15212235
[No Abstract] [Full Text] [Related]
24. The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastoma.
Berry T; Luther W; Bhatnagar N; Jamin Y; Poon E; Sanda T; Pei D; Sharma B; Vetharoy WR; Hallsworth A; Ahmad Z; Barker K; Moreau L; Webber H; Wang W; Liu Q; Perez-Atayde A; Rodig S; Cheung NK; Raynaud F; Hallberg B; Robinson SP; Gray NS; Pearson AD; Eccles SA; Chesler L; George RE
Cancer Cell; 2012 Jul; 22(1):117-30. PubMed ID: 22789543
[TBL] [Abstract][Full Text] [Related]
25. Novel Immunotherapeutic Approaches for Neuroblastoma and Malignant Melanoma.
Morandi F; Frassoni F; Ponzoni M; Brignole C
J Immunol Res; 2018; 2018():8097398. PubMed ID: 30510968
[TBL] [Abstract][Full Text] [Related]
26. Genetic susceptibility to neuroblastoma.
Tolbert VP; Coggins GE; Maris JM
Curr Opin Genet Dev; 2017 Feb; 42():81-90. PubMed ID: 28458126
[TBL] [Abstract][Full Text] [Related]
27. Neuroblastoma: the impact of biology and cooperation leading to personalized treatments.
Owens C; Irwin M
Crit Rev Clin Lab Sci; 2012; 49(3):85-115. PubMed ID: 22646747
[TBL] [Abstract][Full Text] [Related]
28. The R1275Q neuroblastoma mutant and certain ATP-competitive inhibitors stabilize alternative activation loop conformations of anaplastic lymphoma kinase.
Epstein LF; Chen H; Emkey R; Whittington DA
J Biol Chem; 2012 Oct; 287(44):37447-57. PubMed ID: 22932897
[TBL] [Abstract][Full Text] [Related]
29. Association of age at diagnosis and genetic mutations in patients with neuroblastoma.
Cheung NK; Zhang J; Lu C; Parker M; Bahrami A; Tickoo SK; Heguy A; Pappo AS; Federico S; Dalton J; Cheung IY; Ding L; Fulton R; Wang J; Chen X; Becksfort J; Wu J; Billups CA; Ellison D; Mardis ER; Wilson RK; Downing JR; Dyer MA;
JAMA; 2012 Mar; 307(10):1062-71. PubMed ID: 22416102
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive genomics linking between neural development and cancer: neuroblastoma as a model.
Nakagawara A; Ohira M
Cancer Lett; 2004 Feb; 204(2):213-24. PubMed ID: 15013220
[TBL] [Abstract][Full Text] [Related]
31. Targeting ALK in neuroblastoma--preclinical and clinical advancements.
Carpenter EL; Mossé YP
Nat Rev Clin Oncol; 2012 May; 9(7):391-9. PubMed ID: 22585002
[TBL] [Abstract][Full Text] [Related]
32. Anaplastic lymphoma kinase: signalling in development and disease.
Palmer RH; Vernersson E; Grabbe C; Hallberg B
Biochem J; 2009 May; 420(3):345-61. PubMed ID: 19459784
[TBL] [Abstract][Full Text] [Related]
33. [Prognosis of neuroblastoma in childhood. Methods of assessment and clinical use].
Pérel Y; Valteau-Couanet D; Michon J; Lavrand F; Coze C; Bergeron C; Notz A; Plantaz D; Chastagner P; Bernard F; Thomas C; Rubie H
Arch Pediatr; 2004 Jul; 11(7):834-42. PubMed ID: 15234382
[TBL] [Abstract][Full Text] [Related]
34. Oncogenic mutations of ALK in neuroblastoma.
Ogawa S; Takita J; Sanada M; Hayashi Y
Cancer Sci; 2011 Feb; 102(2):302-8. PubMed ID: 21205076
[TBL] [Abstract][Full Text] [Related]
35. ALK pERKs up MYCN in neuroblastoma.
Lindner S; Henssen A; Astrahantseff K; Schulte JH
Sci Signal; 2014 Oct; 7(349):pe27. PubMed ID: 25351246
[TBL] [Abstract][Full Text] [Related]
36. Midkine and Alk signaling in sympathetic neuron proliferation and neuroblastoma predisposition.
Reiff T; Huber L; Kramer M; Delattre O; Janoueix-Lerosey I; Rohrer H
Development; 2011 Nov; 138(21):4699-708. PubMed ID: 21989914
[TBL] [Abstract][Full Text] [Related]
37. High levels of HIF-2alpha highlight an immature neural crest-like neuroblastoma cell cohort located in a perivascular niche.
Pietras A; Gisselsson D; Ora I; Noguera R; Beckman S; Navarro S; Påhlman S
J Pathol; 2008 Mar; 214(4):482-8. PubMed ID: 18189331
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic strategies for the treatment of neuroblastoma.
Izbicka E; Izbicki T
Curr Opin Investig Drugs; 2005 Dec; 6(12):1200-14. PubMed ID: 16370386
[TBL] [Abstract][Full Text] [Related]
39. Cell death-based treatment of neuroblastoma.
Valter K; Zhivotovsky B; Gogvadze V
Cell Death Dis; 2018 Jan; 9(2):113. PubMed ID: 29371588
[TBL] [Abstract][Full Text] [Related]
40. Neuroblastoma pathogenesis: deregulation of embryonic neural crest development.
Tomolonis JA; Agarwal S; Shohet JM
Cell Tissue Res; 2018 May; 372(2):245-262. PubMed ID: 29222693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]